Related references
Note: Only part of the references are listed.Randomised clinical trials: linaclotide phase 3 studies in IBS-C - a prespecified further analysis based on European Medicines Agency-specified endpoints
E. M. M. Quigley et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2013)
A Positive Diagnostic Strategy Is Noninferior to a Strategy of Exclusion for Patients With Irritable Bowel Syndrome
Luise M. Begtrup et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2013)
Eluxadoline Benefits Patients With Irritable Bowel Syndrome With Diarrhea in a Phase 2 Study
Leonard S. Dove et al.
GASTROENTEROLOGY (2013)
Cost-effectiveness of acupuncture for irritable bowel syndrome: findings from an economic evaluation conducted alongside a pragmatic randomised controlled trial in primary care
Eugena Stamuli et al.
BMC GASTROENTEROLOGY (2012)
Global Prevalence of and Risk Factors for Irritable Bowel Syndrome: A Meta-analysis
Rebecca M. Lovell et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2012)
The Yield of Colonoscopy in Patients With Non-Constipated Irritable Bowel Syndrome: Results From a Prospective, Controlled US Trial
William D. Chey et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2010)
Measuring irritable bowel syndrome patient-reported outcomes with an abdominal pain numeric rating scale
B. Spiegel et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2009)
Developing Valid and Reliable Health Utilities in Irritable Bowel Syndrome: Results From the IBS PROOF Cohort
Brennan Spiegel et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2009)
Irritable bowel syndrome: A 10-yr natural history of symptoms and factors that influence consultation behavior
Alexander C. Ford et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2008)
Economic evaluation of tegaserod vs. placebo in the treatment of patients with irritable bowel syndrome:: An analysis of the TENOR study
Andrea Bracco et al.
VALUE IN HEALTH (2007)
Health-related quality of life, work productivity, and health care resource utilization of subjects with irritable bowel syndrome:: Baseline results from LOGIC (longitudinal outcomes study of gastrointestinal symptoms in Canada), a naturalistic study
Pierre Pare et al.
CLINICAL THERAPEUTICS (2006)
Systematic review: the efficacy of treatments for irritable bowel syndrome - a European perspective
J. Tack et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2006)
Determinants of healthcare-seeking behaviour among subjects with irritable bowel syndrome
RE Williams et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2006)
Performance of the EQ-5D in patients with irritable bowel syndrome
DM Bushnell et al.
VALUE IN HEALTH (2006)
Validation of electronic data capture of the irritable bowel syndrome - Quality of life measure, the work productivity and activity impairment questionnaire for irritable bowel syndrome and the EuroQol
DM Bushnell et al.
VALUE IN HEALTH (2006)
Is a negative colonoscopy associated with reassurance or improved health-related quality of life in irritable bowel syndrome?
BMR Spiegel et al.
GASTROINTESTINAL ENDOSCOPY (2005)
Quality of life and illness costs in irritable bowel syndrome
M Simren et al.
DIGESTION (2004)
Health-related quality of life and cost impact of irritable bowel syndrome in a UK primary care setting
RL Akehurst et al.
PHARMACOECONOMICS (2002)
Quality of life in patients with irritable bowel syndrome seen in referral centers versus primary care:: The impact of gender and predominant bowel pattern
M Simrén et al.
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2001)
Irritable bowel syndrome in general practice: prevalence, characteristics, and referral
WG Thompson et al.
GUT (2000)
Share Paper
